Related Experiment Videos
Two different, highly exposed, bulged structures for an unusually long peptide bound to rat MHC class I RT1-Aa
1Department of Molecular Biology and, Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Immunity
|February 13, 2001
Summary
Rat MHC class Ia molecules can bind long peptides, like the minor histocompatibility antigen MTF-E. Structural analysis reveals unique bulged conformations influencing T cell receptor recognition.
Area of Science:
- Immunology
- Structural Biology
- Molecular Biology
Background:
- The rat Major Histocompatibility Complex (MHC) class Ia molecule, RT1-Aa, exhibits an atypical ability to bind extended peptides.
- This includes the thirteen-residue maternally transmitted minor histocompatibility antigen, MTF-E, which possesses two arginine residues potentially serving as anchor points.
Purpose of the Study:
- To elucidate the structural basis of RT1-Aa binding to the long peptide MTF-E.
- To understand how the unique structure of the peptide-MHC (pMHC) complex influences T cell receptor (TCR) engagement.
Main Methods:
- X-ray crystallography was employed to determine the structure of the RT1-Aa-MTF-E complex at 2.55 Å resolution.
- Analysis of the crystal structure focused on peptide conformation and its presentation within the MHC binding groove.
Main Results:
- The crystal structure revealed that both termini of MTF-E are anchored within the RT1-Aa molecule, consistent with other class I MHCs.
- Intriguingly, the central residues of MTF-E adopted distinct bulged conformations in two independent pMHC complexes, driven by local environmental factors.
- The MTF-E epitope was found to be fully accessible within the predicted T cell receptor (TCR) binding site.
Conclusions:
- The observed structural flexibility of the RT1-Aa-MTF-E complex highlights a mechanism for generating diverse TCR responses.
- Chemically identical peptides can present structurally dissimilar epitopes, leading to differential TCR recognition and immune responses.